What is APRE's dilution risk score?

APRE has a latest available DilutionScore record of 51/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for APRE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for APRE?

DilutionWatch tracks 25 SEC filing types for APRE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect APRE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For APRE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for APRE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for APRE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

APRE Dilution Risk Score: 51/100 (HIGH)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

0

📊 Float Risk

27

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 27%

🔄 Reverse Split model est. 55%

• 50-day avg $0.84 below $1 exchange minimum

🔔 Track APRE — Get forecast alerts →

Market Data

Market Cap$11.05M

Shares Outstanding12.59M

Float8.57M

Cash$41.23M

DebtN/A

Short InterestN/A

Institutional Holdings

10 institutional holders · 1.58M shares

#1 AIGH Capital Management LLC 370.5K shares

#2 Murchinson Ltd. 340.1K shares

#3 Sphera Funds Management Ltd. 270.0K shares

+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest41.1K

Days to Cover1.0

% of Float0.5%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

xbrl XBRL WARRANT 2025-12-31

EFFECT EFFECT 2026-04-29

424B3 ATM 2026-04-29

S-3 SHELF 2026-04-22

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual APRE Dilution Snapshot

Aprea Therapeutics, Inc. (APRE) has a DilutionScore of 51/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for APRE: EFFECT on 2026-04-29; 424B3 on 2026-04-29; S-3 on 2026-04-22.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.